A Groundbreaking Milestone in the Treatment of NASH and Liver Fibrosis - Anervea
March 17, 2024 09:19 ET
|
ANERVEA DATA LABS PRIVATE LIMITED
Pune, March 17, 2024 (GLOBE NEWSWIRE) -- The recent FDA approval of Resmetirom, developed by Madrigal Pharmaceuticals, has sent ripples of excitement throughout the medical community, marking a...